Price movement over the last 24 hours
C3.ai Inc vs DexCom, Inc. — how do they compare? C3.ai Inc trades at $8.86 (market cap $1.39B), while DexCom, Inc. trades at $73.79 (market cap $28.39B). The key difference: DexCom, Inc. is far larger — about 20.4× C3.ai Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, C3.ai Inc nearer its low. Which is the better fit depends on your goals.
| AI | DXCM | |
|---|---|---|
Market Cap | $1.39B | $28.39B |
Sector | Technology | Health |
52-Week High | $29.16 | $89.53 |
52-Week Low | $7.76 | $54.84 |
Enterprise Value | $818.29M | $27.36B |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →